Skip to content
Home
Guidelines
Appropriate Use Criteria
Technology Overviews
About Us
Contact
Implementation Resources
Resources
Search for:
Home
Guidelines
Appropriate Use Criteria
Technology Overviews
About Us
Contact
Implementation Resources
Resources
Home
References
Aviles, A., Nambo, M. J., Huerta-Guzman, J., Cleto, S., Neri, N. Prolonged Use of Zoledronic Acid (4 Years) Did Not Improve Outcome in Multiple Myeloma Patients. Clinical lymphoma, myeloma & leukemia 2017; 4: 207-210
PubMed ID:
PM:28284745
Treatment of Metastatic Carcinoma and Myeloma of the Femur
Doseage Response of BMAs
Go to Top